Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Baxter International (DE:BTL)
FRANKFURT:BTL
Baxter International (BTL) Stock Price & Analysis
2 Followers
BTL Stock Chart & Stats
Day’s Range€37.58 - €37.64
52-Week Range― - ―
Previous Close€38.2
Volume0.00
Average Volume (3M)N/A
Market Cap
$19.13B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
May 02, 2024EPS Estimate
€0.57Last Dividend Ex-Date
Feb 29, 2024Dividend Yield2.85%
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€41.37Price Target Upside10.02% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
Baxter International News
PremiumCompany Announcements
Baxter International Weighs Sale Over Spinoff for Kidney CareBulls Say, Bears Say
Bulls Say
Market Share And Sales GrowthWith a considerable market share in the US large volume pump market, BAX's Novum IQ launch is positioned to capture over $200 million in sales.
Product ApprovalFDA clearance of BAX’s Novum IQ large volume pump represents a new revenue stream not included in prior guidance, signaling potential additional earnings.
Strategic DivestitureAnalyst recommends the sale of KidneyCo, which could provide BAX with approximately $2 billion in cash, equivalent to potential spin-off proceeds, transferring stand-up dilution risk to private equity investors.
Bears Say
Product ApprovalAlaris was approved, potentially diminishing the expected market advantage for BAX.
Sales Growth GuidanceBAX's sales growth guidance falls short of market expectations.
Strategic DecisionsExiting KidneyCo could delay BAX's earnings per share growth.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
2.36% Other Institutional Investors
97.64% Public Companies and
Individual Investors
BTL FAQ
What was Baxter International’s price range in the past 12 months?
Currently, no data Available
What is Baxter International’s market cap?
Currently, no data Available
When is Baxter International’s upcoming earnings report date?
Baxter International’s upcoming earnings report date is May 02, 2024 which is yesterday.
How were Baxter International’s earnings last quarter?
Baxter International released its earnings results on Feb 08, 2024. The company reported €0.821 earnings per share for the quarter, beating the consensus estimate of €0.806 by €0.015.
Is Baxter International overvalued?
According to Wall Street analysts Baxter International’s price is currently Undervalued.
Does Baxter International pay dividends?
Baxter International pays a Quarterly dividend of €0.27 which represents an annual dividend yield of 2.85%. See more information on Baxter International dividends here
What is Baxter International’s EPS estimate?
Baxter International’s EPS estimate is €0.57.
How many shares outstanding does Baxter International have?
Currently, no data Available
What happened to Baxter International’s price movement after its last earnings report?
Baxter International reported an EPS of €0.821 in its last earnings report, beating expectations of €0.806. Following the earnings report the stock price went down -2.188%.
Which hedge fund is a major shareholder of Baxter International?
Among the largest hedge funds holding Baxter International’s share is Dodge & Cox. It holds Baxter International’s shares valued at 1B.
---
Baxter International Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€41.37 (10.02% Upside)
€41.37 (10.02% Upside)
Blogger Sentiment
Bullish
DE:BTL Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $2.7M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-12.34%
12-Months-Change
Fundamentals
Return on Equity
-0.44%
Trailing 12-Months
Asset Growth
-0.04%
Trailing 12-Months
Company Description
Baxter International
Founded in 1931 and based in Illinois, Baxter International, Inc. provides a portfolio of healthcare products. The company focuses on transformative innovation to deliver smarter, more personalized care for patients and providers. It operates through six global businesses: Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery and Acute Therapies.
---
BTL Company Deck
---
BTL Earnings Call
Q4 2024
0:00 / 0:00
---
BTL Net sales Breakdown
33.83% Medical Products and Therapies
30.06% Kidney Care
20.34% Healthcare Systems and Technologies
15.18% Pharmaceuticals
0.59% Other
---
BTL Stock 12 Months Forecast
Average Price Target
€41.37
▲(10.02% Upside)
Technical Analysis
Best Analysts Covering BTL
1 Year
1 Year Success Rate
8/20 ratings generated profit
1 Year Average Return
-2.73%
assigned a buy rating last month
Copying Matt Miksic's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of -2.73% per trade.
---